MedTrace Logo

Primary Hyperoxaluria Mutation Genotyping

NCT00589225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 902

Last updated 2016-07-07

No results posted yet for this study

Summary

This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.

Conditions

  • Primary Hyperoxaluria

Interventions

GENETIC

Genetic Analysis

We will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Oxalosis and Hyperoxaluria Foundation (OHF)

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Dawn Milliner, MD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00589225 on ClinicalTrials.gov